7 completed, 2 terminated, 1 active not recruiting. 10 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 7, Terminated 2, Active not recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Myocet: new trials by email Literature Review of Myocet trials Research Report on Myocet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer Carboplatin, Paclitaxel, Doxorubicin - Breast Cancer, Triple Negative Breast Cancer | Phase 2 | Completed | University of Wisconsin, Madison | 29 | 2017-11-07 | 2026-02-13 |
| A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Brentuximab vedotin, Rituximab, Cyclophosphamide - Diffuse Large B-Cell Lymphoma | Phase 2 | Active not recruiting | Patrick Reagan | 24 | 2016-06-01 | 2025-08-12 |
| Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb RCOMP, RCHOP - Lymphoma | Phase 2 | Completed | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 91 | 2013-10-11 | 2024-02-26 |
| Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer Carboplatin, background treatment - Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II | Phase 2 / Phase 3 | Completed | GBG Forschungs GmbH | 595 | 2011-08-01 | 2016-02-15 |
| Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients Metformin + Myocet + Cyclophosphamide, Myocet + Cyclophosphamide - Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Phase 2 | Completed | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 126 | 2010-09-01 | 2016-01-01 |
| Myocet Plus Endoxan for Older Patients With Breast Cancer Cyclophosphamide, Liposomal-encapsulated doxorubicin - Breast Cancer | Phase 2 | Terminated | Hellenic Oncology Research Group | 64 | 2009-09-01 | 2015-10-07 |
| Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma Rituximab, Cyclophosphamide, Doxorubicin - Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | Arbeitsgemeinschaft medikamentoese Tumortherapie | 94 | 2007-12-01 | 2013-08-30 |
| Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin liposomal Doxorubicin, Myocet / Paclitaxel - Metastatic Breast Cancer | Phase 2 | Terminated | Claudia Lorenz-Schlüter | 26 | 2006-12-01 | 2014-09-03 |
| Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients Myocet, Taxotere, Herceptin - Breast Cancer | Phase 1 / Phase 2 | Completed | Spanish Breast Cancer Research Group | 73 | 2004-01-01 | 2023-03-06 |
| A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer trastuzumab, paclitaxel, Myocet - Breast Cancer | Phase 1 / Phase 2 | Completed | Hoffmann-La Roche | 69 | 2001-07-01 | 2015-03-12 |
Breast Neoplasms (6) · Lymphoma, Large B-Cell, Diffuse (2) · Carcinoma, Ductal, Breast (1) · Cardiotoxicity (1) · Inflammatory Breast Neoplasms (1) · Lymphoma (1) · Lymphoma, Follicular (1) · Triple Negative Breast Neoplasms (1)
Arbeitsgemeinschaft medikamentoese Tumortherapie (1) · Claudia Lorenz-Schlüter (1) · GBG Forschungs GmbH (1) · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (1) · Hellenic Oncology Research Group (1) · Hoffmann-La Roche (1) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS (1) · Patrick Reagan (1) · Spanish Breast Cancer Research Group (1) · University of Wisconsin, Madison (1)
Spain (3) · Germany (2) · United States (2) · Austria (1) · Greece (1) · Italy (1)
Dimitris Mavrudis, MD (1) · Dino Amadori, MD (1) · Dr. Alejandro Martin (1) · Dr. Francisco Gual (1) · Dr. Juan Manuel Sancho (1) · Gunter von Minckwitz, MD, Prof (1) · Joachim Bischoff, Dr. med. (1) · Kari Wisinski, MD (1) · Michael A Fridrik, MD (1) · Patrick M Reagan, MD (1)
PMID 15148277, PMID 15226333, PMID 17654614, PMID 19074216, PMID 20007997, PMID 20603435, PMID 20728699, PMID 21892906, PMID 24794243, PMID 25199759, PMID 25534375, PMID 28715532, PMID 32200486, PMID 33492774
2009 (1)